• Something wrong with this record ?

Origin, development and therapy of colorectal cancer from the perspective of a biologist and an oncologist

J. Svec, J. Onhajzer, V. Korinek

. 2024 ; 204 (-) : 104544. [pub] 20241025

Language English Country Netherlands

Document type Journal Article, Review

The intestinal epithelium, a rapidly renewing tissue, is characterized by a continuous cell turnover that occurs through a well-coordinated process of cell proliferation and differentiation. This dynamic is crucial for the long-term function of the gastrointestinal tract. Disruption of this process can lead to colorectal carcinoma, a common malignancy worldwide. The first part of the review focuses on the cellular composition of the epithelium and the molecular mechanisms that control its functions, and describes the pathways that lead to epithelial transformation and tumor progression. This forms the basis for understanding the development and progression of advanced colorectal cancer. The second part deals with current therapeutic approaches and presents the latest treatment options, ongoing clinical trials and new drugs. In addition, the biological and medical perspectives of the adverse effects of therapies and models of regeneration of the intestinal epithelium are highlighted and, finally, future treatment options are discussed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003177
003      
CZ-PrNML
005      
20250206104103.0
007      
ta
008      
250121e20241025ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.critrevonc.2024.104544 $2 doi
035    __
$a (PubMed)39490796
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Svec, Jiri $u Laboratory of Cell and Developmental Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic; Department of Oncology, Third Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic
245    10
$a Origin, development and therapy of colorectal cancer from the perspective of a biologist and an oncologist / $c J. Svec, J. Onhajzer, V. Korinek
520    9_
$a The intestinal epithelium, a rapidly renewing tissue, is characterized by a continuous cell turnover that occurs through a well-coordinated process of cell proliferation and differentiation. This dynamic is crucial for the long-term function of the gastrointestinal tract. Disruption of this process can lead to colorectal carcinoma, a common malignancy worldwide. The first part of the review focuses on the cellular composition of the epithelium and the molecular mechanisms that control its functions, and describes the pathways that lead to epithelial transformation and tumor progression. This forms the basis for understanding the development and progression of advanced colorectal cancer. The second part deals with current therapeutic approaches and presents the latest treatment options, ongoing clinical trials and new drugs. In addition, the biological and medical perspectives of the adverse effects of therapies and models of regeneration of the intestinal epithelium are highlighted and, finally, future treatment options are discussed.
650    _2
$a lidé $7 D006801
650    12
$a kolorektální nádory $x terapie $x patologie $7 D015179
650    _2
$a střevní sliznice $x patologie $x účinky léků $7 D007413
650    _2
$a onkologové $7 D000072103
650    _2
$a zvířata $7 D000818
650    _2
$a nádorová transformace buněk $7 D002471
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Onhajzer, Jakub $u Laboratory of Cell and Developmental Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Korinek, Vladimir $u Laboratory of Cell and Developmental Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic. Electronic address: vladimir.korinek@img.cas.cz
773    0_
$w MED00005043 $t Critical reviews in oncology/hematology $x 1879-0461 $g Roč. 204 (20241025), s. 104544
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39490796 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104059 $b ABA008
999    __
$a ok $b bmc $g 2263119 $s 1239184
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 204 $c - $d 104544 $e 20241025 $i 1879-0461 $m Critical reviews in oncology/hematology $n Crit Rev Oncol Hematol $x MED00005043
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...